{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:14:21Z","timestamp":1782224061664,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["GAP 103"],"award-info":[{"award-number":["GAP 103"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["OLP-0088"],"award-info":[{"award-number":["OLP-0088"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1653-x","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T21:00:00Z","timestamp":1539205200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis"],"prefix":"10.1186","volume":"16","author":[{"given":"Pradeep K.","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathi Babu","family":"Chodisetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep K.","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Janmeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed N.","family":"Agrewala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"1653_CR1","unstructured":"Organization WH: Global tuberculosis report 2017. In: Global tuberculosis report 2017. 2017."},{"key":"1653_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molmed.2012.07.008","volume":"18","author":"U Gowthaman","year":"2012","unstructured":"Gowthaman U, Rai PK, Khan N, Jackson DC, Agrewala JN. Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions. Trends Mol Med. 2012;18:607\u201314.","journal-title":"Trends Mol Med"},{"key":"1653_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","volume":"3","author":"P Andersen","year":"2005","unstructured":"Andersen P, Doherty TM. The success and failure of BCG\u2014implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3:656\u201362.","journal-title":"Nat Rev Microbiol"},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1471-4906(01)01865-8","volume":"22","author":"P Andersen","year":"2001","unstructured":"Andersen P. TB vaccines: progress and problems. Trends Immunol. 2001;22:160\u20138.","journal-title":"Trends Immunol"},{"key":"1653_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","volume":"8","author":"HM Dockrell","year":"2017","unstructured":"Dockrell HM, Smith SG. What have we learnt about BCG vaccination in the last 20\u00a0years? Front Immunol. 2017;8:1134.","journal-title":"Front Immunol"},{"key":"1653_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2014","unstructured":"Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, Sterne JA. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58:470\u201380.","journal-title":"Clin Infect Dis"},{"key":"1653_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.vaccine.2005.01.069","volume":"23","author":"GA Rook","year":"2005","unstructured":"Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine. 2005;23:2115\u201320.","journal-title":"Vaccine"},{"key":"1653_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/infdis\/jir548","volume":"204","author":"U Gowthaman","year":"2011","unstructured":"Gowthaman U, Singh V, Zeng W, Jain S, Siddiqui KF, Chodisetti SB, Gurram RK, Parihar P, Gupta P, Gupta UD, et al. Promiscuous peptide of 16\u00a0kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response. J Infect Dis. 2011;204:1328\u201338.","journal-title":"J Infect Dis"},{"key":"1653_CR9","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1073\/pnas.0406740101","volume":"101","author":"DC Jackson","year":"2004","unstructured":"Jackson DC, Lau YF, Le T, Suhrbier A, Deliyannis G, Cheers C, Smith C, Zeng W, Brown LE. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci USA. 2004;101:15440\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1653_CR10","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.4049\/jimmunol.169.9.4905","volume":"169","author":"W Zeng","year":"2002","unstructured":"Zeng W, Ghosh S, Lau YF, Brown LE, Jackson DC. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J Immunol. 2002;169:4905\u201312.","journal-title":"J Immunol"},{"key":"1653_CR11","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1753::AID-IMMU1753>3.0.CO;2-B","volume":"29","author":"JN Agrewala","year":"1999","unstructured":"Agrewala JN, Wilkinson RJ. Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa alpha-crystallin antigen of Mycobacterium tuberculosis. Eur J Immunol. 1999;29:1753\u201361.","journal-title":"Eur J Immunol"},{"key":"1653_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1365-2249.1998.00724.x","volume":"114","author":"JN Agrewala","year":"1998","unstructured":"Agrewala JN, Wilkinson RJ. Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kD alpha-crystallin antigen of Mycobacterium tuberculosis. Clin Exp Immunol. 1998;114:392\u20137.","journal-title":"Clin Exp Immunol"},{"key":"1653_CR13","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","volume":"30","author":"LA Pinxteren van","year":"2000","unstructured":"van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol. 2000;30:3689\u201398.","journal-title":"Eur J Immunol"},{"key":"1653_CR14","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1517\/14712598.2014.951630","volume":"14","author":"N Bruffaerts","year":"2014","unstructured":"Bruffaerts N, Huygen K, Romano M. DNA vaccines against tuberculosis. Expert Opin Biol Ther. 2014;14:1801\u201313.","journal-title":"Expert Opin Biol Ther"},{"key":"1653_CR15","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1016\/j.vaccine.2016.06.077","volume":"34","author":"N Ritz","year":"2016","unstructured":"Ritz N, Casalaz D, Donath S, Tebruegge M, Dutta B, Connell TG, Robins-Browne R, Britton WJ, Hanekom WA, Curtis N. Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia. Vaccine. 2016;34:4132\u20139.","journal-title":"Vaccine"},{"key":"1653_CR16","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1128\/IAI.71.12.7173-7177.2003","volume":"71","author":"L Majlessi","year":"2003","unstructured":"Majlessi L, Rojas MJ, Brodin P, Leclerc C. CD8+ -T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. Infect Immun. 2003;71:7173\u20137.","journal-title":"Infect Immun"},{"key":"1653_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.4049\/jimmunol.168.2.834","volume":"168","author":"RM Coles","year":"2002","unstructured":"Coles RM, Mueller SN, Heath WR, Carbone FR, Brooks AG. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J Immunol. 2002;168:834\u20138.","journal-title":"J Immunol"},{"key":"1653_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1086\/421116","volume":"190","author":"N Sharma","year":"2004","unstructured":"Sharma N, Agrewala JN. Potent role of vaccines prepared from macrophages infected with live bacteria in protection against Mycobacterium tuberculosis and Salmonella typhimurium infections. J Infect Dis. 2004;190:107\u201314.","journal-title":"J Infect Dis"},{"key":"1653_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/sj.gene.6364392","volume":"8","author":"FF Weichold","year":"2007","unstructured":"Weichold FF, Mueller S, Kortsik C, Hitzler WE, Wulf MJ, Hone DM, Sadoff JC, Maeurer MJ. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun. 2007;8:334\u201343.","journal-title":"Genes Immun"},{"key":"1653_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.4049\/jimmunol.169.3.1444","volume":"169","author":"CW McMahon","year":"2002","unstructured":"McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, Raulet DH. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J Immunol. 2002;169:1444\u201352.","journal-title":"J Immunol"},{"key":"1653_CR21","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","volume":"181","author":"EK Forbes","year":"2008","unstructured":"Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, Beverley PC, Tchilian EZ. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol. 2008;181:4955\u201364.","journal-title":"J Immunol"},{"key":"1653_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fimmu.2017.01262","volume":"8","author":"DA Lewinsohn","year":"2017","unstructured":"Lewinsohn DA, Lewinsohn DM, Scriba TJ. Polyfunctional CD4(+) T cells as targets for tuberculosis vaccination. Front Immunol. 2017;8:1262.","journal-title":"Front Immunol"},{"key":"1653_CR23","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","volume":"182","author":"T Lindenstrom","year":"2009","unstructured":"Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol. 2009;182:8047\u201355.","journal-title":"J Immunol"},{"key":"1653_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1086\/318817","volume":"183","author":"CS Hirsch","year":"2001","unstructured":"Hirsch CS, Toossi Z, Johnson JL, Luzze H, Ntambi L, Peters P, McHugh M, Okwera A, Joloba M, Mugyenyi P, et al. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis. 2001;183:779\u201388.","journal-title":"J Infect Dis"},{"key":"1653_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2249.2011.04381.x","volume":"164","author":"C Ni Cheallaigh","year":"2011","unstructured":"Ni Cheallaigh C, Keane J, Lavelle EC, Hope JC, Harris J. Autophagy in the immune response to tuberculosis: clinical perspectives. Clin Exp Immunol. 2011;164:291\u2013300.","journal-title":"Clin Exp Immunol"},{"key":"1653_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","volume":"8","author":"SA Khader","year":"2007","unstructured":"Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8:369\u201377.","journal-title":"Nat Immunol"},{"key":"1653_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","volume":"41","author":"SA Khader","year":"2008","unstructured":"Khader SA, Cooper AM. IL-23 and IL-17 in tuberculosis. Cytokine. 2008;41:79\u201383.","journal-title":"Cytokine"},{"key":"1653_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1086\/653827","volume":"202","author":"V Singh","year":"2010","unstructured":"Singh V, Gowthaman U, Jain S, Parihar P, Banskar S, Gupta P, Gupta UD, Agrewala JN. Coadministration of interleukins 7 and 15 with bacille Calmette\u2013Guerin mounts enduring T cell memory response against Mycobacterium tuberculosis. J Infect Dis. 2010;202:480\u20139.","journal-title":"J Infect Dis"},{"key":"1653_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clim.2018.01.003","volume":"188","author":"A Narsale","year":"2018","unstructured":"Narsale A, Moya R, Davies JD. Human CD4(+) CD25(+) CD127(hi) cells and the Th1\/Th2 phenotype. Clin Immunol. 2018;188:103\u201312.","journal-title":"Clin Immunol"},{"key":"1653_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cytogfr.2014.07.012","volume":"25","author":"JJ Zaunders","year":"2014","unstructured":"Zaunders JJ, Levy Y, Seddiki N. Exploiting differential expression of the IL-7 receptor on memory T cells to modulate immune responses. Cytokine Growth Factor Rev. 2014;25:391\u2013401.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1653_CR31","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1021\/mp300257x","volume":"9","author":"AC Tan","year":"2012","unstructured":"Tan AC, Mifsud EJ, Zeng W, Edenborough K, McVernon J, Brown LE, Jackson DC. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. Mol Pharm. 2012;9:2710\u20138.","journal-title":"Mol Pharm"},{"key":"1653_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1084\/jem.20070322","volume":"204","author":"H Hikono","year":"2007","unstructured":"Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, Woodland DL. Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med. 2007;204:1625\u201336.","journal-title":"J Exp Med"},{"key":"1653_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","volume":"8","author":"JI Moliva","year":"2017","unstructured":"Moliva JI, Turner J, Torrelles JB. Immune responses to bacillus Calmette\u2013Guerin vaccination: why do they fail to protect against Mycobacterium tuberculosis? Front Immunol. 2017;8:407.","journal-title":"Front Immunol"},{"key":"1653_CR34","doi-asserted-by":"publisher","first-page":"e23360","DOI":"10.1371\/journal.pone.0023360","volume":"6","author":"B Dey","year":"2011","unstructured":"Dey B, Jain R, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis. PLoS ONE. 2011;6:e23360.","journal-title":"PLoS ONE"},{"key":"1653_CR35","first-page":"8","volume":"2017","author":"R Lang","year":"1864","unstructured":"Lang R, Schick J. Review: impact of helminth infection on antimycobacterial immunity\u2014a focus on the macrophage. Front Immunol. 1864;2017:8.","journal-title":"Front Immunol"},{"key":"1653_CR36","first-page":"119","volume":"123","author":"PR Narayanan","year":"2006","unstructured":"Narayanan PR. Influence of sex, age and nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India. Indian J Med Res. 2006;123:119\u201324.","journal-title":"Indian J Med Res"},{"key":"1653_CR37","first-page":"553","volume":"94","author":"CE Palmer","year":"1966","unstructured":"Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966;94:553\u201368.","journal-title":"Am Rev Respir Dis"},{"key":"1653_CR38","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.4049\/jimmunol.165.11.6073","volume":"165","author":"HJ Ullrich","year":"2000","unstructured":"Ullrich HJ, Beatty WL, Russell DG. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J Immunol. 2000;165:6073\u201380.","journal-title":"J Immunol"},{"key":"1653_CR39","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1128\/IAI.01826-06","volume":"75","author":"SL Young","year":"2007","unstructured":"Young SL, Slobbe L, Wilson R, Buddle BM, de Lisle GW, Buchan GS. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infect Immun. 2007;75:2833\u201340.","journal-title":"Infect Immun"},{"key":"1653_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrmicro1688","volume":"5","author":"SH Kaufmann","year":"2007","unstructured":"Kaufmann SH. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol. 2007;5:491\u2013504.","journal-title":"Nat Rev Microbiol"},{"key":"1653_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2217\/fon.12.125","volume":"8","author":"JA Cintolo","year":"2012","unstructured":"Cintolo JA, Datta J, Mathew SJ, Czerniecki BJ. Dendritic cell-based vaccines: barriers and opportunities. Future Oncol. 2012;8:1273\u201399.","journal-title":"Future Oncol"},{"key":"1653_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.170.2.527","volume":"170","author":"K Inaba","year":"1989","unstructured":"Inaba K, Romani N, Steinman RM. An antigen-independent contact mechanism as an early step in T cell-proliferative responses to dendritic cells. J Exp Med. 1989;170:527\u201342.","journal-title":"J Exp Med"},{"key":"1653_CR43","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/eji.1830250511","volume":"25","author":"A Mehta-Damani","year":"1995","unstructured":"Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD4+ T cell lines from naive precursors. Eur J Immunol. 1995;25:1206\u201311.","journal-title":"Eur J Immunol"},{"key":"1653_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","volume":"26","author":"JS Woodworth","year":"2006","unstructured":"Woodworth JS, Behar SM. Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit Rev Immunol. 2006;26:317\u201352.","journal-title":"Crit Rev Immunol"},{"key":"1653_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-017-1301-x","volume":"15","author":"PK Rai","year":"2017","unstructured":"Rai PK, Chodisetti SB, Zeng W, Nadeem S, Maurya SK, Pahari S, Janmeja AK, Jackson DC, Agrewala JN. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity. J Transl Med. 2017;15:201.","journal-title":"J Transl Med"},{"issue":"Suppl 1","key":"1653_CR46","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1093\/infdis\/jiu568","volume":"212","author":"SA Plotkin","year":"2015","unstructured":"Plotkin SA. Increasing complexity of vaccine development. J Infect Dis. 2015;212(Suppl 1):S12\u20136.","journal-title":"J Infect Dis"},{"key":"1653_CR47","first-page":"4","volume-title":"Tait D","author":"M Hatherill","year":"2016","unstructured":"Hatherill M. Tait D. Microbiol Spectr: Clinical testing of tuberculosis vaccine candidates; 2016. p. 4."},{"key":"1653_CR48","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","volume":"381","author":"MD Tameris","year":"2013","unstructured":"Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 2013;381:1021\u20138.","journal-title":"Lancet"},{"key":"1653_CR49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1084\/jem.20121190","volume":"210","author":"MA Curran","year":"2013","unstructured":"Curran MA, Geiger TL, Montalvo W, Kim M, Reiner SL, Al-Shamkhani A, Sun JC, Allison JP. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J Exp Med. 2013;210:743\u201355.","journal-title":"J Exp Med"},{"key":"1653_CR50","doi-asserted-by":"publisher","first-page":"854507","DOI":"10.1155\/2015\/854507","volume":"2015","author":"IV Lyadova","year":"2015","unstructured":"Lyadova IV, Panteleev AV. Th1 and Th17 Cells in tuberculosis: protection, pathology, and biomarkers. Mediators Inflamm. 2015;2015:854507.","journal-title":"Mediators Inflamm"},{"key":"1653_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm.2285","volume":"17","author":"C Aagaard","year":"2011","unstructured":"Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med. 2011;17:189\u201394.","journal-title":"Nat Med"},{"key":"1653_CR52","first-page":"2","volume":"1","author":"A Grave","year":"2011","unstructured":"Grave A, Hokey D. Tuberculosis vaccines: review of current development trends and future challenges. J Bioterr Biodef S. 2011;1:2.","journal-title":"J Bioterr Biodef S"},{"key":"1653_CR53","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1086\/499953","volume":"42","author":"AC Hesseling","year":"2006","unstructured":"Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, Gie RP, Cotton MF, van Helden PD, Warren RM, Beyers N. Bacille Calmette\u2013Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006;42:548\u201358.","journal-title":"Clin Infect Dis"},{"key":"1653_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/imr.12272","volume":"264","author":"S Boisson-Dupuis","year":"2015","unstructured":"Boisson-Dupuis S, Bustamante J, El-Baghdadi J, Camcioglu Y, Parvaneh N, El Azbaoui S, Agader A, Hassani A, El Hafidi N, Mrani NA, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015;264:103\u201320.","journal-title":"Immunol Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1653-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1653-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1653-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T19:23:17Z","timestamp":1570735397000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1653-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1653-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"14 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"279"}}